<SEC-DOCUMENT>0001654954-16-004708-index.html : 20161209
<SEC-HEADER>0001654954-16-004708.hdr.sgml : 20161209
<ACCEPTANCE-DATETIME>20161209130558
ACCESSION NUMBER:		0001654954-16-004708
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20161209
DATE AS OF CHANGE:		20161209

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bioptix, Inc.
		CENTRAL INDEX KEY:			0001167419
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				841553387
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-79102
		FILM NUMBER:		162043512

	BUSINESS ADDRESS:	
		STREET 1:		1775 38TH STREET
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-545-5550

	MAIL ADDRESS:	
		STREET 1:		1775 38TH STREET
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Venaxis, Inc.
		DATE OF NAME CHANGE:	20121218

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AspenBio Pharma, Inc.
		DATE OF NAME CHANGE:	20051110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ASPENBIO INC
		DATE OF NAME CHANGE:	20020213

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DeFrancesco Catherine Johanna
		CENTRAL INDEX KEY:			0001684226

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	MAIL ADDRESS:	
		STREET 1:		365 BAY STREET
		STREET 2:		SUITE 840
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5H 2V1

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DeFrancesco Catherine Johanna DeFrancesco
		DATE OF NAME CHANGE:	20160908
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>defrancesco13da_dec72016.htm
<DESCRIPTION>SCHEDULE 13D/A
<TEXT>
Document 1 - file: defrancesco13da_dec72016.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<DESCRIPTION>TRANSACTIONS IN SHARES
<TEXT>
Document 2 - file: ex1-1.htm

</DOCUMENT>
</SEC-DOCUMENT>